GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annovis Bio Inc (FRA:07X) » Definitions » Change In Prepaid Assets

Annovis Bio (FRA:07X) Change In Prepaid Assets : €0.14 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Annovis Bio Change In Prepaid Assets?

Annovis Bio's Change In Prepaid Assets for the quarter that ended in Mar. 2025 was €-1.04 Mil. It means Annovis Bio's Prepaid Assets declined by €1.04 Mil from Dec. 2024 to Mar. 2025 .

Annovis Bio's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was €1.03 Mil. It means Annovis Bio's Prepaid Assets increased by €1.03 Mil from Dec. 2023 to Dec. 2024 .


Annovis Bio Change In Prepaid Assets Historical Data

The historical data trend for Annovis Bio's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annovis Bio Change In Prepaid Assets Chart

Annovis Bio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Prepaid Assets
Get a 7-Day Free Trial -0.03 -0.24 -6.92 2.93 1.03

Annovis Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.21 3.37 -0.61 -1.58 -1.04

Annovis Bio Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Annovis Bio Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Annovis Bio's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Annovis Bio Business Description

Traded in Other Exchanges
Address
101 Lindenwood Drive, Suite 225, Malvern, PA, USA, 19355
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Annovis Bio Headlines

No Headlines